enbucrilate has been researched along with Ewing Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, K; He, A; Shen, Z; Sun, Y; Yao, Y; Zhang, J; Zheng, S | 1 |
| Bertrand, JR; Couvreur, P; Elhamess, H; Fattal, E; Hillaireau, H; Maccario, J; Maksimenko, A; Malvy, C; Tamaddon, A; Toub, N | 1 |
1 trial(s) available for enbucrilate and Ewing Sarcoma
| Article | Year |
|---|---|
Cyclophosphamide-hydroxycamptothecin as second-line chemotherapy for advanced Ewing's sarcoma: experience of a single institution.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Enbucrilate; Female; Humans; Male; Middle Aged; Sarcoma, Ewing; Young Adult | 2014 |
1 other study(ies) available for enbucrilate and Ewing Sarcoma
| Article | Year |
|---|---|
Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma.
Topics: Animals; Cyanoacrylates; Enbucrilate; Fibroblasts; Mice; Mice, Nude; Nanoparticles; Nanotechnology; NIH 3T3 Cells; Oncogene Proteins, Fusion; Polymers; Proto-Oncogene Protein c-fli-1; RNA Interference; RNA-Binding Protein EWS; RNA, Messenger; RNA, Small Interfering; Sarcoma, Ewing; Time Factors; Transfection | 2006 |